Migraine: disease characterisation, biomarkers, and precision medicine

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Migraine : disease characterisation, biomarkers, and precision medicine. / Ashina, Messoud; Terwindt, Gisela M.; Al-Karagholi, Mohammad Al Mahdi; de Boer, Irene; Lee, Mi Ji; Hay, Debbie L.; Schulte, Laura H.; Hadjikhani, Nouchine; Sinclair, Alexandra J.; Ashina, Håkan; Schwedt, Todd J.; Goadsby, Peter J.

I: The Lancet, Bind 397, Nr. 10283, 17.04.2021, s. 1496-1504.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Ashina, M, Terwindt, GM, Al-Karagholi, MAM, de Boer, I, Lee, MJ, Hay, DL, Schulte, LH, Hadjikhani, N, Sinclair, AJ, Ashina, H, Schwedt, TJ & Goadsby, PJ 2021, 'Migraine: disease characterisation, biomarkers, and precision medicine', The Lancet, bind 397, nr. 10283, s. 1496-1504. https://doi.org/10.1016/S0140-6736(20)32162-0

APA

Ashina, M., Terwindt, G. M., Al-Karagholi, M. A. M., de Boer, I., Lee, M. J., Hay, D. L., Schulte, L. H., Hadjikhani, N., Sinclair, A. J., Ashina, H., Schwedt, T. J., & Goadsby, P. J. (2021). Migraine: disease characterisation, biomarkers, and precision medicine. The Lancet, 397(10283), 1496-1504. https://doi.org/10.1016/S0140-6736(20)32162-0

Vancouver

Ashina M, Terwindt GM, Al-Karagholi MAM, de Boer I, Lee MJ, Hay DL o.a. Migraine: disease characterisation, biomarkers, and precision medicine. The Lancet. 2021 apr. 17;397(10283):1496-1504. https://doi.org/10.1016/S0140-6736(20)32162-0

Author

Ashina, Messoud ; Terwindt, Gisela M. ; Al-Karagholi, Mohammad Al Mahdi ; de Boer, Irene ; Lee, Mi Ji ; Hay, Debbie L. ; Schulte, Laura H. ; Hadjikhani, Nouchine ; Sinclair, Alexandra J. ; Ashina, Håkan ; Schwedt, Todd J. ; Goadsby, Peter J. / Migraine : disease characterisation, biomarkers, and precision medicine. I: The Lancet. 2021 ; Bind 397, Nr. 10283. s. 1496-1504.

Bibtex

@article{28864a22b53a45c48fae7401f7f2f933,
title = "Migraine: disease characterisation, biomarkers, and precision medicine",
abstract = "Migraine is a disabling neurological disorder, diagnosis of which is based on clinical criteria. A shortcoming of these criteria is that they do not fully capture the heterogeneity of migraine, including the underlying genetic and neurobiological factors. This complexity has generated momentum for biomarker research to improve disease characterisation and identify novel drug targets. In this Series paper, we present the progress that has been made in the search for biomarkers of migraine within genetics, provocation modelling, biochemistry, and neuroimaging research. Additionally, we outline challenges and future directions for each biomarker modality. We also discuss the advances made in combining and integrating data from multiple biomarker modalities. These efforts contribute to developing precision medicine that can be applied to future patients with migraine.",
author = "Messoud Ashina and Terwindt, {Gisela M.} and Al-Karagholi, {Mohammad Al Mahdi} and {de Boer}, Irene and Lee, {Mi Ji} and Hay, {Debbie L.} and Schulte, {Laura H.} and Nouchine Hadjikhani and Sinclair, {Alexandra J.} and H{\aa}kan Ashina and Schwedt, {Todd J.} and Goadsby, {Peter J.}",
year = "2021",
month = apr,
day = "17",
doi = "10.1016/S0140-6736(20)32162-0",
language = "English",
volume = "397",
pages = "1496--1504",
journal = "The Lancet",
issn = "0140-6736",
publisher = "TheLancet Publishing Group",
number = "10283",

}

RIS

TY - JOUR

T1 - Migraine

T2 - disease characterisation, biomarkers, and precision medicine

AU - Ashina, Messoud

AU - Terwindt, Gisela M.

AU - Al-Karagholi, Mohammad Al Mahdi

AU - de Boer, Irene

AU - Lee, Mi Ji

AU - Hay, Debbie L.

AU - Schulte, Laura H.

AU - Hadjikhani, Nouchine

AU - Sinclair, Alexandra J.

AU - Ashina, Håkan

AU - Schwedt, Todd J.

AU - Goadsby, Peter J.

PY - 2021/4/17

Y1 - 2021/4/17

N2 - Migraine is a disabling neurological disorder, diagnosis of which is based on clinical criteria. A shortcoming of these criteria is that they do not fully capture the heterogeneity of migraine, including the underlying genetic and neurobiological factors. This complexity has generated momentum for biomarker research to improve disease characterisation and identify novel drug targets. In this Series paper, we present the progress that has been made in the search for biomarkers of migraine within genetics, provocation modelling, biochemistry, and neuroimaging research. Additionally, we outline challenges and future directions for each biomarker modality. We also discuss the advances made in combining and integrating data from multiple biomarker modalities. These efforts contribute to developing precision medicine that can be applied to future patients with migraine.

AB - Migraine is a disabling neurological disorder, diagnosis of which is based on clinical criteria. A shortcoming of these criteria is that they do not fully capture the heterogeneity of migraine, including the underlying genetic and neurobiological factors. This complexity has generated momentum for biomarker research to improve disease characterisation and identify novel drug targets. In this Series paper, we present the progress that has been made in the search for biomarkers of migraine within genetics, provocation modelling, biochemistry, and neuroimaging research. Additionally, we outline challenges and future directions for each biomarker modality. We also discuss the advances made in combining and integrating data from multiple biomarker modalities. These efforts contribute to developing precision medicine that can be applied to future patients with migraine.

U2 - 10.1016/S0140-6736(20)32162-0

DO - 10.1016/S0140-6736(20)32162-0

M3 - Review

C2 - 33773610

AN - SCOPUS:85103935054

VL - 397

SP - 1496

EP - 1504

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 10283

ER -

ID: 261515875